HCID 10171570, compound → HCID 10125445, compound
Reaction equation
[CH:1]1([NH:4][C:5]2[C:10]([CH3:11])=[C:9]([N:12]3[CH2:17][CH2:16][C:15](C)([CH3:18])[CH2:14][CH2:13]3)[N:8]=[C:7]([CH:20]3[CH2:22][CH2:21]3)[N:6]=2)[CH2:3][CH2:2]1.C1(NC2C(C)=C(N3CCC(C)CC3)N=C(C3CC3)N=2)CC1.C12CC(CC1)CN(C1N=C(C3CC3)N=C(NC3CC3)C=1C)C2.C1(NC2C(C)=C(N3CCSCC3)N=C(C3CC3)N=2)CC1.N1(C2C3CCCNC=3N=C(C3CC3)N=2)CCCCCC1.N1(C2C3CCCCNC=3N=C(C3CC3)N=2)CCCCCC1>>[N:12]1([C:9]2[N:8]=[C:7]([CH:20]3[CH2:21][CH2:22]3)[N:6]=[C:5]([NH:4][CH:1]3[CH2:2][CH2:3]3)[C:10]=2[CH3:11])[CH2:17][CH2:16][CH2:18][CH2:15][CH2:14][CH2:13]1Participants
7
Procedure
N,2-dicyclopropyl-6-(4,4-dimethyl-1-piperidinyl)-5-methyl-4-pyrimidinamine; N,2-dicyclopropyl-5-methyl-6-(4-methyl-1-piperidinyl)-4-pyrimidinamine; 6-(3-azabicyclo[3.2.1]oct-3-yl)-N,2-dicyclopropyl-5-methyl-4-pyrimidinamine; N,2-dicyclopropyl-5-methyl-6-(4-thiomorpholinyl)-4-pyrimidinamine; 4-azepan-1-yl-2-cyclopropyl-5,6,7,8-tetrahydro-pyrido[2,3-d]pyrimidine and 4-azepan-1-yl-2-cyclopropyl-6,7,8,9-tetrahydro-pyrimido[4,5-b]azepine, or pharmaceutically acceptable salts thereof.
Sources & evidence
- ORD record
- ord-f754d61a29a740bb97ddd973c8af1a91
- Source dataset
- uspto-grants-2009_06
- Patent number
- US07544675B2
Reaction notes
Loading…